Japanese Industrial REITs Stock News

Chugai Pharmaceutical (TSE:4519) opened 2026 with Q1 revenue of ¥321,747 million and basic EPS of ¥70.13, setting the tone off the back of a year where trailing twelve month revenue reached about ¥1.29 trillion and EPS came in at ¥274.77. Over recent quarters the company has seen revenue move from ¥288,459 million and EPS of ¥59.09 in Q1 2025 to ¥346,301 million and EPS of ¥78.04 in Q4 2025, giving you a clear view of the top line and per share earnings trend heading into the latest print...

Hitachi Construction Machinery FY 2026 earnings snapshot Hitachi Construction Machinery (TSE:6305) has reported its FY 2026 fourth quarter with revenue of ¥426.1 billion and basic EPS of ¥79.85, giving investors a fresh read on how the business is converting a sizeable top line into per share earnings. Over recent periods, the company has seen quarterly revenue range from ¥306.2 billion to ¥426.1 billion, with basic EPS moving between ¥53.03 and ¥124.43, while on a trailing twelve month basis...

KOA (TSE:6999) has put fresh numbers on the table for FY 2026, with fourth quarter revenue of ¥19.2 billion and basic EPS of ¥21.25, backed by trailing twelve month revenue of ¥72.3 billion and EPS of ¥106.40 that reflects a very large year over year earnings jump off a low base. The company has seen quarterly revenue move from ¥16.4 billion in Q4 FY 2025 to ¥19.2 billion in Q4 FY 2026, while EPS shifted from a loss of ¥5.66 to a profit of ¥21.25 over the same period, presenting a story where...

Buyback plan puts Kubota’s capital return in focus Kubota (TSE:6326) has put a fresh spotlight on its capital return policy after the Board authorized a share repurchase program covering up to 1.3% of issued share capital. See our latest analysis for Kubota. The buyback decision comes after a period of firm gains, with Kubota’s share price delivering a 14.14% year to date return and contributing to a 58.71% 1 year total shareholder return, which suggests positive momentum in how the market...

Recent performance snapshot Inpex (TSE:1605) has drawn attention after a 2.6% gain over the past day and 2.2% over the past week, in contrast with an 8.3% decline over the past month but a 26.1% rise over the past 3 months. See our latest analysis for Inpex. The recent pullback, including a 1 month share price return of negative 8.3%, sits against a stronger backdrop. A 3 month share price return of 26.1% and a 1 year total shareholder return above 100% suggest that momentum has been building...

Sinfonia Technology Ltd (TSE:6507) has called a board meeting for April 23, 2026 to consider abolishing its policy on large scale share purchases, a move that could reshape its takeover defense posture. See our latest analysis for Sinfonia TechnologyLtd. The board meeting comes at a time when Sinfonia TechnologyLtd’s ¥13,380 share price sits against a 30 day share price return of 9.58% and a year to date share price return of 36.25%. Total shareholder return over five years is very large at...

If you are wondering whether Eisai is starting to look attractively priced or still expensive, the recent share performance gives you a useful starting point. The stock closed at ¥4,735, with a 20.0% return over the last year. Shorter term moves show a 3.2% decline over 7 days, a 2.8% decline over 30 days, and a 1.1% decline year to date, which hints at shifting views on its risk and reward profile. Recent company updates, including progress on its pharmaceutical pipeline and ongoing...

Why Konica Minolta is on investors’ radar Konica Minolta (TSE:4902) has attracted fresh attention after a period of mixed share performance, with the stock showing negative returns over the past week, month, and past 3 months, but a positive 1 year total return. See our latest analysis for Konica Minolta. The recent 1 day share price decline of 10.64% and 90 day share price return of negative 30.33% contrast with a 1 year total shareholder return of 12.59%, suggesting earlier momentum has...

What Terumo’s Recent Share Performance Tells Investors Terumo (TSE:4543) has drawn attention after a period of mixed share performance, with the stock roughly flat over the past month but showing a negative move over the past 3 months and over the past year. See our latest analysis for Terumo. With the share price at ¥2,056.0, Terumo’s 7 day share price return of 5.47% and year to date share price return of 9.13% sit against a 1 year total shareholder return decline of 24.6%. This suggests...

Recent returns and business snapshot Asahi Group Holdings (TSE:2502) has recently drawn attention after a stretch of mixed share returns, including a 0.6% decline in the latest session and weaker performance over the past year. The company operates a broad beverage and food portfolio across Japan, Europe, Oceania, and Southeast Asia, generating revenue of ¥2,926,294 and net income of ¥155,563, with annual revenue growth of 3.9% and net income growth of 10.3%. See our latest analysis for Asahi...

If you are wondering whether Mitsui's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article breaks down what the current numbers say. Mitsui recently closed at ¥5,784, with a 1-year return of 110.0%, a 3-year return of 197.3% and a very large 5-year gain. However, the stock has seen a 0.3% decline over 7 days and a 7.5% decline over 30 days, while the year-to-date return stands at 21.7%. Recent coverage has focused on Mitsui's...

Subaru Canada marked Earth Day 2026 by completing its 10,000 tree planting goal. The company continues its environmental efforts through its partnership with Leave No Trace Canada. Ongoing work under the Adventure On Parks program extends Subaru's focus on conservation across Canadian parks. For investors tracking Subaru (TSE:7270), the environmental update arrives at a time when the share price is around ¥2,447.5 and the stock has seen a 25.3% return over 3 years and 44.3% over 5 years...

Why DAIHEN (TSE:6622) Is Drawing Fresh Attention DAIHEN (TSE:6622) has come onto investors’ radar after its recent share price move, with the stock showing positive returns over the past month and past 3 months. That price action sits against a backdrop of ¥233,973 million in revenue and ¥13,674 million in net income. This has put fresh focus on how the market is currently valuing this Osaka based industrial name. See our latest analysis for DAIHEN. The recent ¥13,900 share price, combined...

Why Komatsu Shares Are Drawing Attention Now Komatsu (TSE:6301) has attracted interest after a recent run, with the share price showing gains over the past month and past 3 months, prompting closer scrutiny of its current valuation and fundamentals. See our latest analysis for Komatsu. That recent run sits on top of a much stronger backdrop, with a 30 day share price return of 7.45% and a 90 day share price return of 21.71%, while the 1 year total shareholder return stands at 76.89%. This...

Event context and recent share performance There is no single headline event driving attention to MS&AD Insurance Group Holdings (TSE:8725) today, but the stock’s recent returns are giving investors a fresh reason to reassess the insurer. Over the past month, the share price has seen a 6.36% decline, extending a 2.69% drop over the past 3 months, even as the year to date return stands at 4.47% and the 1 year total return at 29.07%. See our latest analysis for MS&AD Insurance Group...

Mitsubishi Electric (TSE:6503) is in focus after announcing a proof of concept railway energy management solution for Krakow’s tram network, combining its Serendie digital platform with energy storage systems. See our latest analysis for Mitsubishi Electric. The railway energy management PoC lands at a time when Mitsubishi Electric’s share price has climbed to ¥5,999, with a 30-day share price return of 8.30% and a 1-year total shareholder return of 129.46%, indicating that momentum has been...

Why Tokio Marine Holdings (TSE:8766) is back on radar after a key rating affirmation Tokio Marine Holdings (TSE:8766) is drawing fresh attention after AM Best affirmed strong financial strength and issuer credit ratings for its China subsidiary. This move reinforces the group’s perceived resilience and risk management profile. See our latest analysis for Tokio Marine Holdings. The AM Best affirmation comes as the share price trades at ¥7,176, with a 7 day share price return of 3.5% and a 90...

Last week, you might have seen that BRONCO BILLY Co.,LTD. ( TSE:3091 ) released its quarterly result to the market. The...

Gendai Agency Inc.'s ( TSE:2411 ) recent earnings report didn't offer any surprises, with the shares unchanged over the...

As you might know, Disco Corporation ( TSE:6146 ) just kicked off its latest annual results with some very strong...

NEXON stock performance snapshot NEXON (TSE:3659) has drawn fresh attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. Against that backdrop, investors are weighing the company’s recent annual revenue of ¥475,102 and net income of ¥92,052, alongside reported annual revenue growth of 4.56% and net income growth of 10.44%. See our latest analysis for NEXON. Despite a 19.66% 1 year total...

The quarterly results for Canon Marketing Japan Inc. ( TSE:8060 ) were released last week, making it a good time to...

If you are wondering whether NSK's current share price reflects its true worth, the recent performance gives you plenty to think about. The stock sits at ¥1,161 after a 3% decline over the past week and a 1.8% decline over the past month, yet it is up 17% year to date and 96.1% over the last year. These moves sit against a broader flow of ongoing company updates and industry developments that keep expectations in flux. For investors, that mix of shorter term pullbacks and much stronger 1...

Asahi Kasei (TSE:3407) has completed its acquisition of German biopharmaceutical company Aicuris Anti-infective Cures. The company has also initiated a Phase I clinical trial for AK1940, a new therapy candidate for autoimmune diseases. Both developments mark a shift in focus toward infectious and autoimmune disease treatments within Asahi Kasei's pharmaceutical operations. Asahi Kasei, traditionally known for chemicals, materials, and health care businesses, is steadily building out its...